Sr Director, Global Medical Lead - Bone
Ultragenyx Pharmaceutical Inc.
Position Summary:
ultrafocused – Work together to fearlessly uncover new possibilities
Ultragenyx is seeking a dynamic and experienced physician leader to join the Global Medical Affairs team focused on the rare bone disease franchise. We are preparing for the potential commercialization of a monoclonal antibody therapy for the treatment of Osteogenesis Imperfecta (OI). The leader will be focused on the OI program and Crysvita (burosumab) for XLH.
Reporting to the VP Global/US Medical Affairs and Strategy, is a high-profile position that requires an adaptable leader, willing to take a “hands on” approach in their work and who is comfortable working in a fast-paced intellectual environment. This leader will be adept at leveraging their rare bone disease expertise to advance our mission to change the future of rare disease medicine.
Work Model:
Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed.
Responsibilities:
- Lead the Global Medical Sub Team (GMST), ensuring regional medical affairs are involved in and inform the development of global medical strategy
- Develop and drive the timely execution of the Global Medical Plan for the bone franchise assets across pre-launch, launch, and post-launch phases
- Serve as the strategic medical leader on the Program Core Team and related sub teams, providing expertise to shape development, commercialization, and lifecycle decisions, taking a “hands on” approach to proactive identify and resolve challenges
- Lead Key Opinion Leader advisory boards, steering committees, and investigator meetings to gather key insights that inform program strategy and activities
- Lead updates of the Integrated Evidence Generation Plan (IEP), ensuring alignment with HEOR and clinical development to address global/regional evidence gaps
- Lead and successfully complete global medical affairs data generation activities, including real-world evidence (RWE), investigator-sponsored trials (ISTs), and other strategic evidence initiatives
- Accountable as the medical affairs lead for Disease Monitoring Programs for rare bone disease, providing strategic medical leadership on all aspects of the studies and accountable for leading data generation and publication activities aligned to the IEP
- Provide deep disease area and product expertise, ensuring accurate and consistent communication of clinical and scientific data
- Lead global publication strategy and congress planning activities, ensuring timely, high-impact dissemination of data and other education initiatives
- Ensure development of impactful core scientific resources (slide decks, FAQs, educational materials) for adaptation by regional teams
- Provide strategic guidance, tools, and training to regional and affiliate medical affairs teams to ensure launch readiness and consistent scientific exchange, and lead internal scientific training for the programs
- Build and maintain relationships with global key opinion leaders (KOLs), societies, and advocacy groups to inform strategy and amplify scientific reach
- Accountable for the medical assessment of the competitor environment and providing direction on strategic implications
- Collaborate effectively with cross-functional partners including clinical development, HEOR, diagnostics, scientific communications and publications, regulatory, market access, commercial, training, and patient advocacy
Requirements:
- Medical Doctor (MD, PhD strongly preferred) with Board Certification in Pediatric/Adult Endocrinology, Clinical/Biochemical Genetics or Orthopedics (required)
- Proven expertise in the management of patients with rare metabolic bone disorders
- Recognized scientific authority with the ability to engage in advanced scientific and clinical discussions with both internal and external experts
- A "hands-on" leader who operates with a sense of urgency and is willing to be directly involved in the development and execution of strategic plans and problem-solving
- Proven leadership skills including a passion for collaboration and understanding all stakeholder perspectives to drive alignment and decision-making
- High aptitude for attention to detail, commitment to high-quality work, and a sense of passion and urgency to achieve goals and improve the lives of patients
- Proven ability to take initiative and drive successful execution of complex projects
- Highly analytical and strategic thinker with the ability to identify interdependencies, consider medical implications, and understand the broader goals of a program and the organization
- Excellent communication skills, with the ability to effectively articulate scientific and strategic concepts in both written documents and verbal presentations
- Demonstrated success leading cross functional or multidisciplinary teams, ideally in both academia and biotech
- Willingness and ability to travel up to 15%, including domestic and international engagements.
#LI-CS1 #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at talentacquisition@ultragenyx.com.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.